In my first article, I will dive into a company trading below excess net cash that is growing more than 20% a year, has a record backlog, and provides a significant dividend yield, all for 6x P/E
Share this post
A Needle in the Haystack
Share this post
In my first article, I will dive into a company trading below excess net cash that is growing more than 20% a year, has a record backlog, and provides a significant dividend yield, all for 6x P/E